Validea Detailed Fundamental Analysis

Johnson & Johnson (JNJ) received an 88% rating from Validea's Partha Mohanram P/B Growth Investor model, positioning it as a stock of significant interest for growth-oriented investors in the large-cap Biotechnology & Drugs sector. This academically-derived model, known for identifying low book-to-market stocks with sustained growth potential and historical market outperformance, found JNJ's underlying fundamentals and valuation largely align with its criteria, despite a noted 'fail' in the Research and Development to Assets metric.

Analysis

Johnson & Johnson (JNJ) has been identified as a compelling large-cap growth stock within the Biotechnology & Drugs sector, scoring a high rating of 88% on Validea's P/B Growth Investor model. This model, based on the academic strategy of Partha Mohanram, is designed to find low book-to-market stocks with fundamental indicators of sustained future growth. The 88% score signifies notable interest from the strategy. JNJ demonstrates significant fundamental strength by passing key tests for Return on Assets (ROA), Cash Flow from Operations to Assets, low variance in both ROA and sales, and a favorable book-to-market ratio. These factors collectively indicate strong operational efficiency, consistent profitability, and stable cash generation. However, the analysis also flags a specific weakness, as JNJ failed the model's criterion for Research and Development to Assets, suggesting its R&D expenditure relative to its asset base does not meet the model's threshold for a high-growth company.

Key Decisions for Investors

• Given the strong 88% quantitative rating and positive signals on core fundamentals like ROA and cash flow, growth-focused investors may consider JNJ an attractive candidate for accumulation.
• Investors should conduct further due diligence on the 'fail' rating for the Research and Development to Assets metric to understand if it reflects a lag in innovation pipeline investment or is a structural consequence of JNJ's large and diverse asset base.
• While the Partha Mohanram model provides a strong endorsement, it is crucial to use this as one input and cross-reference the findings with other valuation methods and qualitative analysis of the company's long-term strategy.